A detailed history of First Turn Management, LLC transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, First Turn Management, LLC holds 455,953 shares of SBTX stock, worth $0. This represents 1.48% of its overall portfolio holdings.

Number of Shares
455,953
Previous 669,010 31.85%
Holding current value
$0
Previous $8.42 Billion 5.46%
% of portfolio
1.48%
Previous 1.7%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
N/A
-213,057 Reduced 31.85%
455,953 $7.96 Billion
Q1 2025

May 15, 2025

BUY
N/A
75,719 Added 12.76%
669,010 $8.42 Billion
Q3 2024

Nov 07, 2024

BUY
N/A
593,291 New
593,291 $8.6 Billion

Others Institutions Holding SBTX

About Silverback Therapeutics, Inc.


  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track First Turn Management, LLC Portfolio

Follow First Turn Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Turn Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Turn Management, LLC with notifications on news.